跳至主要内容
临床试验/CTRI/2022/02/040207
CTRI/2022/02/040207尚未招募2 期

Supplementary Intravesical Sodium Butyrate to Intravesical Bacillus Calmette-Guérin in Non Muscle Invasive Bladder Cancer: A Study on the Tumour Immuno-microenvironment and A Meta-transcriptomic and Microbiome analysis.

AIIMS Bhubaneswar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosed cases of NMIBC who are candidates for Adjuvant Intravesical BCG therapy.

排除标准

  • Patients not consenting to participate in the trial.
  • Patients with active UTI.
  • Patients Muscle invasive bladder cancer
  • Patients with incomplete resection on the previous TURBT.
  • Patients who received antibiotics in the past one month.
  • Patients with prior pelvic Radiotherapy for any cause.
  • Patients of T1G3/T1High-Grade being considered for â??earlyâ?? Radical cystectomy.
  • Patients with non-urothelial (TCC) bladder cancer undergoing Radical Cystectomy.
  • Patient performance status ECOG greater than 2.

研究者

相似试验